Here's Why You Should Add Maximus Stock to Your Portfolio Now

Zacks
11 Mar

Maximus, Inc. MMS stands out as a strong investment opportunity, backed by solid fundamentals and a favorable Zacks rating. The company’s consistent financial performance, strategic acquisitions and strong government partnerships position it well for continued growth. With a history of stable dividend payments and a healthy liquidity position, Maximus demonstrates resilience and reliability in the market.

Let’s take a closer look at what makes MMS an attractive choice for investors.

MMS carries a Zacks Rank #2 (Buy) and a VGM Score of B. Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition.

The Zacks Consensus Estimate for fiscal 2025 earnings is pegged at $6.08, up 2% in the past 60 days. Two estimates for fiscal 2025 earnings have been revised upward, with no downward revisions in this time frame.

With more than 40 years of experience, Maximus has grown to be a leading operator of government health and human services programs globally. The company’s business process management expertise and its ability to deliver cost-effective, efficient and high-scale solutions position it as a lucrative partner to governments.

Maximus maintains solid relationships and a strong reputation with governments. Its long-term contracts provide the company with predictable recurring revenue streams. It continuously seeks long-term relationships with clients in not only those markets where they operate but also in adjacent ones.

Maximus, Inc. Revenue (TTM)

Maximus, Inc. revenue-ttm | Maximus, Inc. Quote

Maximus has been active on the acquisition front,and this strategy has enabled itto expand its business processes, knowledge and client relationships, enhance technical capabilities and gain additional skill sets. Strategic acquisitions also complement the company’s long-term organic growth strategy. The 2022 acquisition of Stirling Institute of Australia, which provides vocational training to Australians seeking to improve their knowledge and qualifications, has strengthened its employment services. Another acquisition, BZ Bodies, has strengthened Maximus’ services within the U.K.

The company has a solid track record of dividend payments. During fiscal 2021, 2022, 2023 and 2024, Maximus paid cash dividends of $68.8 million, $68.7 million, $68 million and $72.9 million, respectively. These steady payouts indicate the company’s commitment to create value for shareholders and underline its confidence in its business.

Maximus' current ratio (a measure of liquidity) at the end of first-quarter fiscal 2025 was pegged at 1.72, higher than the industry’s 1.45. A current ratio of more than 1 indicates that the company should not have problems meeting its short-term obligations.

Other Stocks to Consider

Some other top-ranked stocks in the broader Zacks Business Services sector are AppLovin Corporation APP and Booz Allen Hamilton BAH.

AppLovin Corporation currently sports a Zacks Rank of 1. You can see the complete list of today’s Zacks #1 Rank stocks here.

APPhas a long-term earnings growth expectation of 20%. It delivered a trailing four-quarter earnings surprise of 23.5%, on average.

Booz Allen Hamilton currently carries a Zacks Rank #2. BAH has a long-term earnings growth expectation of 14%. BAH has an impressive earnings surprise history, having outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed once. The average beat is 6.7%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Booz Allen Hamilton Holding Corporation (BAH) : Free Stock Analysis Report

Maximus, Inc. (MMS) : Free Stock Analysis Report

AppLovin Corporation (APP) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10